Subtractive hybridisation was used to screen for and identify conserved DNA sequences associated with clinical, clonal populations of Staphylococcus aureus. DNA from S. aureus strain ISPS (a clinical isolate) was digested with TaqI and hybridised with randomly fragmented pooled DNA from 10 non-clinical (community) isolates of S. aureus. The mixture of DNA fragments was then ligated to AccI-digested and dephosphorylated pTZl9U. One recombinant plasmid (pWASA) was identified as containing specific DNA from strain ISP8; DNA sequencing revealed a 40-bp TaqI DNA fragment (WASA). PCR amplification and hybridisation analysis, with pWASA as a probe, showed that 84% of clinical isolates from a clonal line present in hospitals in major eastern Australian cities carried sequences homologous to WASA, compared with only 10% of community isolates. The isolates that hybridised were closely related by RFLP analysis to strain ISPS. The plasmid pWASA was used to identify, isolate and clone a 3.5-kb DraI fragment (DSA) from strain ISP8 total DNA. Sequence analysis of the DSA fragment identified two open reading frames (ORFs) of 2475 and 576bp, respectively; the larger O W 1 contained a series of six tandem repeats, each consisting of 384 nucleotides. The nucleotide sequence of the repeats was 96% identical, and no significant sequence homologies to previously described protein sequences were identified. However, tandem repeats of amino acids are structural motifs characteristic of a number of gram-positive surface proteins, and are thought to play a role in generating genetic and phenotypic diversity in these and other bacteria.
Introduction
The ability of a bacterial pathogen to colonise a host, invade tissue, and cause disease is the result of a complex interaction of bacterial, host and environmental factors. However, not all strains of a pathogenic bacterial species are equally virulent, and many disease syndromes are caused by bacterial strains that belong to a few clones [l-41. Restriction fragment length polymorphism (RFLP) analysis of community isolates and of methicillin-sensitive clinical isolates of StaphyZococcus aureus (MSSA) showed that these two groups were not closely related, with a few exceptions, to each other, nor to the multi-resistant (MRSA) types [5] . This absence of clonality in the MSSA and community isolates, despite their well conserved genomic organisation [5] , suggests that strains with the greatest clinical impact arise from single or a few progenitors, which are or become singularly well-adapted as pathogens. These then become dominant through selection and are evident as closely related (clonal) lines. This raises questions as to whether successful pathogenic clones are equipped with particular combinations or arrangements of genes that are strongly selected through interaction with the vulnerable host and the clinical environment, and proliferate on that host or in that environment. Thus, an important question is raised: is it possible to predict virulence on the basis of the presence and arrangements of genes or DNA sequences in different staphylococcal lineages, i.e., on purely genetic evidence, without making assumptions about the production of particular enzymes or proteins by individual staphylococcal isolates or clones? If this is the case for S. aureus, then such predictor genes or sequences might be identified by selective molecular cloning techniques.
This report describes experiments that identify the presence of conserved DNA sequences, characteristic of clonal, clinical S. aureus strains, which are absent from non-clonal community strains, i.e., DNA sequences that are potential virulence determinants. This has been done by subtractive hybridisation and cloning of specific DNA sequences by methods used previously for identifying DNA sequences specific for the mouse Y-chromosome [6] . A similar approach has also been applied previously to cloning DNA sequences present in one cell population but not in another [7-lo] .
Materials and methods

Bacterial strains and antibiotic susceptibilities
S. aureus strain 8325-4 (ISP8) [ l l ] was kindly provided by Dr P. Pattee, Iowa State University. The standard reference NCTC strain 8325 (parent of ISP8) was isolated originally in England in the 1950s from a clinical environment [ 121 and is similar to recent types of MRSAs and some recent MSSAs isolated in Australia [5] . Strain ANS46 is a multi-resistant S. aureus (MRSA), studied extensively in this and other laboratories, and is a representative of a clonal group referred to as type 46 (and subtypes within) that was dominant in major hospitals in the eastern Australian states during the period 1982-1986 [5, 8, 13-19] . MRSA strain Ib is representative of a group referred to as type I (subtype b), while type I1 isolate represents the type I1 group of MRSA prevalent in Canberra hospitals during the period 1989-1990 [5, 17, 191. Strains SK565 and SK597 are from a collection of MRSA isolates [20] kindly provided by Professor R. A. Skurray, University of Sydney. These MRSA isolates were hospital-acquired and were isolated from patients with systemic infections during outbreaks of MRSA infection.
Clinical MSSA isolates were isolated from patients with minor staphylococcal infections admitted to Woden Valley Hospital, Canberra in 1993; these isolates were resistant to three or fewer antibiotics of the nine commonly tested for this organism and were not involved in infection outbreaks. Community S. aureus isolates were collected by nasal swabbing from a random selection of healthy university students with no history of hospitalisation, staphylococcal infection or disease, or antibiotic use, in Canberra during 1990; these isolates were, in general, resistant to not more than one antibiotic. Isolates were identified as S. aureus by growth and mannitol fermentation on NaCl 5% w/v Nutrient Agar (Oxoid) and by a positive coagulase test. Antibiotic susceptibilities were tested with the BBL Sensi-Disc System (Becton Dickinson) by measuring and comparing zones of inhibition of growth around antibiotic impregnated disks with those for standard resistant and sensitive strains, as described by the manufacturer.
DNA preparation
Growth and preparation of cells for total cellular DNA preparation was as described previously [8] . DNA in agarose plugs was prepared as described by Inglis et al. [16] and Stewart et al. [21] . Plasmid DNA from Escherichia coli was prepared by the alkaline lysis method [22] , with the addition of a digestion step with lysozyme 4 mg/ml for 10 min at room temperature.
Electrophoresis
Clamped homogeneous electric field (CHEF DRII; BioRad, CA, USA) gel electrophoresis was in agarose 1% w/v gels at 200 V for a total of 26 h at 12-14°C in Tris-borate buffer (45 m~ Tris, 45 mM boric acid, 1 mM EDTA, pH 8.3) with the following pulse parameters: first set, 23 s for 4 h; second set, ramped with initial forward time of 1 s and final forward time of 40 s for 22 h [5, 211. After electrophoresis, gels were stained with ethidium bromide 0.5 mg/L, destained in water and photographed over a UV transilluminator. Characterisation and classification of the isolates into types or groups was on the basis of WLP analysis and estimates of genetic distances [5] .
Experimental strategy for construction of an ISP8 difference DNA library by subtructive hybridisation
The strategy applied was to hybridise total DNA from two sources: first, endonuclease-digested total DNA from a representative strain of the clinical population, putatively containing DNA of gene(s) associated specifically with the clinical population; and second, pooled and sheared total DNA from community (nonclinical) isolates. The latter shares most of the sequences found in the clinical isolate, except for the putative specific gene(s). By using an excess of community DNA to drive the hybridisation to completion, and so block the cloning of DNA sequences common to both the clinical and community DNA, the cloning of DNA sequences associated specifically with the clinical isolate may be achieved.
S. aureus NCTC strain 8325-4 (ISP8) was used as the standard strain representative of the clinical population; detailed genetic information is available for this strain [23] . ISP8 is related to the recent clinical types identified in major hospitals on the eastern Australian coast [5], but does not carry any of the known repeat sequences -such as IS elements, tranposons, plasmids, or bacteriophages -identified previously in staphylococci [23, 241 (P. Pattee, personal communication) .
Thus, ISP8 DNA (20 pg) was digested for 17 h with restriction endonuclease Taq T (50 U) (Pharmacia). Total cellular DNA from 10 community S. aureus isolates was pooled, sheared, denatured and fragmented as described by Matthews et al. [8] . Sheared DNA from community S. aureus isolates was then mixed with TaqI-digested ISP8 DNA at a mass ratio of 200:1, boiled at 100°C for 10 min, and then allowed to anneal at 65°C for c. 18 h.
Cloning of difference DNA
A 0.5-pg sample of the annealed DNA mix (i.e., TaqIdigested ISP8 DNA and sheared DNA from community S. aureus isolates) was mixed with AccI (Pharmacia)-digested, dephosphorylated plasmid pTZ 19U DNA (BioRad) at a mass ratio of 1O:l in the presence of T4 DNA ligase (Pharmacia) at 10 U/50 pl of ligation buffer. The ligation reaction was performed at 16°C for 17 h. A sample of the ligation mix was used to transform electrocompetent E. coli strain MC 106 1.1 (a recA-derivative of strain MC1061 obtained from Dr C. Rice, Washington University Medical School, St Louis, MO, USA). Transformed bacteria were grown on ampicillin-containing (50 pglml) Luria Agar medium [22] .
Screening transformants for ISP8 DNA
Transformed bacteria were identified by growth on ampicillin-containing (50 pg/ml) Luria agar medium, and were screened for recombinant plasmids as follows. Sterile toothpicks were used to pick wellisolated colonies from the plates of transformed cells and were dipped into 25 pl of freshly prepared cracking solution (50mM NaOH, SDS 0.5% w/v, 5 mM EDTA, glycerol 10% v/v, bromocresol green 0.0 1 % w/v), twirled quickly, then discarded. The samples were then heated at 68°C for 30 min, cooled to room temperature, loaded on to an agarose 1% w/v gel, and electrophoresed (K. C. Reed, personal communication).
For pWASA, recombinant plasmids were identified by Southern transfer and hybridisation to total DNA probes from ISP8 and from community isolates (see below).
For pDSA, the polymerase chain reaction (PCR) was also used to screen pools of transformed clones to identify those with specific staphylococcal sequences. Briefly, pools of 10 transformed colonies were suspended in 0.5 ml of sterile distilled water and boiled at 100°C for 10 min. A 5-pl volume was used in a PCR to amplify the specific target sequences with WSA 3' and WSA 2R primers (Table 1) designed from sequence information obtained from genomic sequencing (see Results). Each PCR reaction mix (20 pl total volume) consisted of 10 mM Tris-HCl, pH 9.0, 50 mM KC1, 1.5 mM MgC12, gelatin 0.01% w/v, Triton X-100 0.1% v/v, 0.2 mM dNTP (each), 5 pmol primers (each), and 0.2 u Super Taq DNA polymerase (PH Stehelin and CIE AG, Basel, Switzerland). PCR conditions with a FTS 4000 Thermal Sequencer (Corbett Research, Sydney, Australia) were as follows: 3 min at 94°C; 35 cycles of 10 s at 94"C, 10 s at 60°C and 20 s at 72°C; 3 rnin at 72 "C; and 5min at 30°C. Amplification products from different pooled samples (colonies) were electrophoresed [22] , and stained. Where a particular pool produced a product, a second round of PCR amplification was performed on each of the constituent colonies in the pool to identify the clone with the target sequence.
Southern transfer and hybridisation
Recombinant plasmids and fragments of Hind111 or SmaI-digested DNA were resolved by agarose gel electrophoresis (CHEF for Sma I fragments) [ 17, 2 11, transferred to membranes (Hybond N+ ; Amersham International), and hybridised to radioactively-labelled DNA probes by the method of Reed [25] . Radiolabelled DNA probes were prepared by random-priming [26, 271 with the Megaprime DNA Labelling System (Amersham) from: (i) total chromosomal DNA from strain ISP8; (ii) community isolates; and (iii) recombinant plasmids carrying ISP8-specific DNA.
Sequencing of 3.5 kb DraI cloned DNA fragment
The Erase-a-Base system (Promega) was used to generate a series of unidirectional deletions, in both directions, fi-om the recombinant 3.5-kb Dra I fragment. The double-stranded DNA from all deletion products was sequenced on an ABI (Applied Biosystems) model 373A version 1.2.1 system at the Biomolecular Resources Facility (JCSMR, ANU, Canberra, Australia) with the universal primers -21M13 and OT7, and the Taq DyeDeoxy Terminator Cycle Sequencing Kit (Prism; Applied Biosystems).
Results
Antibiotic susceptibilities
Strains ANS46, type lb, type IT, SK565 and SK597 were resistant to penicillin, methicillin, tetracycline, chloramphenicol, gentamicin, erythromycin and kanamycin. Strain ISP8 was susceptible to all seven antibiotics. Clinical MSSA isolates expressed resistance to three or fewer antibiotics (penicillin, tetracycline and erythromycin). Other than penicillin, the community isolates were susceptible to all antibiotics tested, except one isolate that was also resistant to erythromycin and tetracycline, and one isolate that was resistant also to erythromycin.
Isolation of E. coli transformants containing ISP8-specijc DNA
Recombinant plasmid DNA was prepared from 12 E. coli transformants and examined for specific ISP8 DNA by hybridisation to DNA probes generated from ISP8 total DNA, and from the pooled total DNA from community isolates. One recombinant plasmid (pWA-SA) that hybridised only to the total ISP8 DNA probe was identified (Fig. 1, lane 4) . DNA sequencing revealed that it carried a 40-bp TaqI fragment. The sequence of this TaqI fragment yielded no significant matches in the GenBank database (NCBI, NIH, USA).
To determine the distribution and the association of specific ISP8 DNA with different S. aureus isolates, pWASA was used to probe Hind111 fragments from 20 clinical isolates (including MRSA and MSSA) and 20 community isolates (different from the isolates used in the initial subtractive hybridisation process). pWASA hybridised, under stringent conditions, to a corresponding fragment in 12 (60%) of 20 clinical isolates and three (10%) of 30 community isolates (Fig. 2) . The isolates that hybridised belonged to a group of genetically closely related types (i.e., members of a clonal population) as defined by RFLP analysis [5, 17, 191 . The MRSA RFLP types were identified as type 46, type Ib and type I1 [5, 17, 191 , while the MSSA isolates (S5 and S6) and community isolates (Cog, Co19 and Co32) had RFLP types closely related to that of ISP8 (Fig. 3) . The MSSA isolate S174 was 
methods).
The DNA used in this reaction was gel-purified DraIdigested ISP8 genomic DNA within the 2-4 kb region identified as containing a 3.5-kb fragment carrying WASA. Cycle sequencing was successful with primer WSA 3', and c. 300 bp of DNA sequence was obtained in one direction. Another primer (WSA 2; Table 1 ) was designed from the 300-bp sequence and was used to extend, in the same direction as in WSA 3', the DNA sequence information by cycle sequencing. An extra 229 bp of sequence was obtained with primer WSA 2, and thus a total of 529 bp of sequence in this direction was compiled. Although the same DNA template was used with both the WSA 5' and WSA 3' primers, no sequence information was obtained with the former. This might be explained by the nature of the nucleotide sequence of the DNA template in that particular direction, i.e., rich in A and T nucleotides, or by the presence of repeat sequences similar to the WSA 5 ' sequence, causing annealing of the primer at multiple sites.
Analysis of the 529-bp sequence revealed multiple open reading frames (ORFs) with no significant similarities to either DNA or (after translation) to amino-acid sequences deposited in the GenBank database. The primers used to screen transformants for ISP8 DNA, i.e., for pDSA, as described in the following section, were designed from WASA and from the compiled 529-bp sequence information.
Isolation of a DraI fragment from ISP8 carrying WASA
pWASA hybridised to a c. 3.5-kb LkaI fragment, a 13-kb AccI fragment, a 10-kb XbaI fragment, a 3.6-kb 
Features of the DSA sequence
The sequenced DSA fragment was examined for ORFs in the six possible frames with MacVector 3.5 software (IBI). Two ORFs were identified: ORFl of 2475 bp, encoding 824 amino acids, starting with the initiation codon ATG at nucleotide 179 (another possible start codon was TTG at nucleotide 191), and terminating with the stop codon TGA at nucleotide 2650. A possible Shine-Dalgarno [29] sequence (ribosome binding site, RBS) was found 14 nucleotides upstream from the ATG start codon, and several potential -35 and -10 promoter sequences were also identified (data not shown). Although there was another ATG start codon at nucleotide 41, it is unlikely that it is utilised because there is no potential RBS upstream from this posit ion.
ORF2 of 576 bp, encoding 192 amino acids, was identified in the third translational frame, starting with a GTG initiation codon at nucleotide 2880 and terminating with a TAG codon at position 3456. RBS and promoter sequences were identified at c'. molecular sizc than those shown. Molecular sizes were ANS46 S i i i u I fragments [ 161.
60 bp (-35 and -10) upstream from the GTG start codon. It is noteworthy that the sequence homology and the position of the promoter sequences with respect to this putative initiation codon do not conform with consensus sequences from other bacteria (data not shown). Although GTG is not a commonly used initiation codon, it has been reported to have this function in the synthesis of several bacterial proteins [30] . Codon usage analysis revealed a preference for A:T bases at the third position of the codons with only 21% G:C, which is similar to other structural genes of S. uiii-eiis [3 I].
Repeating unit region qf' ORFl
Beginning at nucleotide 265 of the sequence of ORFI, there are six tandem repeats that make up c. 66% of the sequence. Each repeating unit consists of 384 nucleotides, encoding 128 amino acids, and the entire repeat region encodes 768 amino acids (Fig. 5 ) . The six repeats are similar, differing only in 16-19 nucleotides of the 384 bases; most of the variations occur at the same nucleotide positions within each repeat unit (Fig. 5 ) . Of the nucleotide variations, nine resulted in eight amino-acid differences between the peptide sequences of the repeats, whereas the remaining variations were silent nucleotide substitutions.
Ana1vsi.s of' the deduced aniino-acid seyiience . fbr ORFl and ORF2
A hydropathy profile of the deduced amino-acid sequence from both ORFs shows a pronounced hydrophilic character for the predicted polypeptides ( Fig. 6 ) . Also shown are the surface probability, antigenic index and secondary structure generated with the MacVector 3.5 software. The features revealed are characteristic for surface proteins from gram-positive bacteria. The deduced amino-acid sequence for ORFl and ORF2 predicts PI values of 4.83 and 8.75, respectively, and calculated mol. wts of 90 783 Da and 2 1 038 Da, respectively. Both predicted protein products are rich in lysinc and proline, with each making up about 13% of the total amino acids in the translated products.
A BLAST search for similarities identified limited amino-acid sequence similarities of ORF 1 with the surface-associated C protein (1 antigen of group B streptococci, collagen (1 type proteins and neurofilament triplet proteins from man and mouse. It is noteworthy that ORF 1 has a similar genetic structure , , , 6 . Analysis of the deduced amino-acid sequence of both ORFl and ORF2. The predicted hydrophilicity profile was determined according to Kyte and Doolittle [32] with a window of seven amino acid residues. The vertical axis indicates the relative hydrophilicity (positive values) or relative hydrophobicity (negative values). The horizontal axis denotes the amino-acid residues. Surface probability, antigenic index and secondary structuri. predictions were determined with the Mac Vector 3.5 (IBI) computer software, which utilises a combination of algorithms. Values > 0.5 (surface probability) indicate amino acids exposed to the surface; values > 0.0 (antigenic index) indicate surface peaks that might be antigenic sites. CF, ; RG, Robson-Garnier method [34] ; C'fRg, a method for secondary structure prediction combining the latter two; Hlx, helix; Sht, sheet; Trn, turn.
to the C a antigen gene, which contains nine identical 246 nucleotide tandem repeating units. The shared similarities between the C a antigen protein and
ORFl encompassed the repeated region, with 26% of amino acids identical and 18% conservative substitutions over a region of 642 amino acids (Fig. 7) .
Similarly, ORF2 amino-acid sequence analysis showed limited homologies to proline-rich proteins such as sporozoite surface protein 2 from Plasmodium yoelii, neurofilament triplet M protein from chicken, and a glutamic acid-specific endopeptidase from S. aureus (data not shown).
Discussion
The observed clonality of MRSA populations that dominate Australian hospitals [5, 17, 191 suggests that clonal, clinical isolates are equipped specifically with some factor(s) that operate within the hospital environment, leading to selection of the clonal population. Studies by Le Clerc and coworkers [35] have revealed that certain subsets of E. coli and Salmonella have a higher than normal mutation rate, and these subsets are common among the pathogenic strains of these bacteria [35] . This suggests that such subsels might be better equipped to adapt in a challenging cnvironment.
This study aimed to begin an identification, at the genetic level, of factors associated specifically with clonal populations of 5' . aureus. The search for differences between clonal, clinical isolates and community isolates was based on the assumption that the former are equipped with specific genes or DNA that is associated preferentially with the virulent lineages. Examination of pathogenic bacterial populations has shown that virulence is not associated randomly with clones [36, 371 . Particular clones appear to be more important than members of the population at large. For example, Musser et al. [3] showed that a single clone of S. aureus was responsible for most cases of toxic shock syndrome in worldwide collections of S. auwus producing the toxin TSST-1. Accordingly, using the strategy of subtractive hybridisation, a 3.5-kb DraI DNA fragment (DSA) was identified, cloned and sequenced from the clinically isolated ISP8 strain. Hybridisation analysis revealed this DNA fragment to be present in the genomes of all MRSA isolates iested. It was also present, at lower frequency (c. 30%) in the genomes 
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* -* * * * ** * * * * , . * * * * * * -* * * * * * . 1982-1993 [5, 17, 191 . These isolates were closely related to the standard strain ISP8 isolated originally in the UK during the 1950s from a clinical environment [12] ; i.e., they appear to have a common clonal background. The MSSA isolates were not involved in outbreaks and, with the exception of strains S5 and S6 (Fig. 3) , were not related closely to each other or to the other clonal group [5] . There is no evidence to indicate that these MSSAs were involved in severe infections, colonisation or spread within the hospital environment.
The fact that closely related MRSA and MSSA types coexist in the clinical environment [28] suggests that certain types of selection, other than those exerted by antibiotic usage, select for the successful type(s) in the clinical environment. DSA may occur more frequently in the clinical clonal population because it encodes functions that are related directly to virulence, or is linked genetically with other genes related to virulence [38-411. In any case, such sequences may prove valuable in the epidemiological tracking and early identification of clinically significant isolates of S. aureus.
Analysis of the ORFl sequence in DSA revealed genetic structural properties shared by a number of gram-positive genes coding for cell surface proteins that are thought to be involved in the pathology of these bacteria [42] . Genes encoding protein A, collagen adhesin and fibronectin-binding protein of S. m i w i s , and M proteins of group A streptococci, IgG binding proteins from both group A and G streptococci, and the C protein a antigen of group B streptococci have been reported to consist of tandemly repeated regions that are highly homologous (within a gene) and are thought to be a result of a series of stepwise gene duplication events [42-451. It is possible that the nucleotide repeats in these genes are important for generating genotypic and phenotypic variability by acting as sites for gene re-arrangements leading to deletion or duplication events, resulting in evolved antigenic diversification. Also, it is possible that duplication of DNA is a mechanism to amplify point mutations within a repeat, which again would create antigenic diversity [42] .
Although a search for possible amino-acid signal sequences was carried out, none was identified. This is similar to the situation reported with a S. uiiiwis peptidoglycan hydrolase (amidase) gene, lytA, which has been reported to lack a signal sequence [46] . Whether the failure to identify signal sequences for ORFl and ORF2, is a result of sequence divergence or the loss of the sequences requires analysis. Interestingly, a tetrapeptide (LPTG), similar to the pentapeptide consensus LPXTG which has been found to be conserved among other gram-positive surface proteins and is thought to mediate the binding of surface proteins to the cell wall [47] , appears throughout ORF1. A similar sequence, LPKTG, was identified in ORF2 at the C-terminal end of this amino-acid sequence, which might likewise be important for cell wall anchoring [47] . Further analyses are in progress to identify these proteins, their properties and the mechanisms involved in their synthesis and secretion, and to examine their importance in the pathogenesis of S. aiirezis infections.
